Regulation & policy

Coke may be about to find out whether the FTC agrees with the NCL that its Vitaminwater claims are

Coke Vitaminwater best beware the FTC, says food attorney

By Shane Starling

The Federal Trade Commission (FTC) is likely to aggressively pursue immunity claims being made by Coca-Cola Vitaminwater after it was called on to investigate them by the Washington DC-based National Consumers League (NCL) this week, a food law attorney...

Montana firm warned over GMP transgressions

Montana firm warned over GMP transgressions

By Shane Starling

Failing to follow manufacturing records, inappropriate batch production records and poor packaging and label control have been cited by the FDA in a recent post GMP inspection warning letter to a Montana manufacturer.

FDA warns niacin marketers about drug claims

By Shane Starling

The Food and Drug Administration has affirmed the principal that references to scientific studies can amount to drug claims under the Federal Food, Drug, and Cosmetic Act (FDCA).

European nutrition science will go on, but will it earn health claims?

Special edition: Outsourcing

CROs (slowly) piece together EFSA's health claim science puzzle

By Shane Starling

In the second part of this special series on global outsourcing trends NutraIngredients explores how the European Union nutrition and health claims regulation (NHCR) is impacting activity in the contract research organisation (CRO) sector.

POM Wonderful wants action in the courts sooner rather than later

POM Wonderful urges court ruling on FTC claims dispute

By Shane Starling

Californian-based pomegranate juice leader POM Wonderful has filed a motion in a Washington DC District Court urging a ruling on its September action against Federal Trade Commission (FTC) claims policing policies.

Pharma research? Nutra research? Perhaps both...

CRN: IND guidance could run against spirit of DSHEA

By Shane Starling

As the Food and Drug Administration (FDA) prepares final guidance on Investigational New Drugs (INDs) a leading trade group has warned of the damaging effect on nutrient research that could follow if the application of INDs is not modified from the current...

Dr Shao: GMP guidance is useful in parts but lacks detail

FDA GMP guidance “won’t provide all the answers”, says CRN

By Shane Starling

Freshly issued FDA GMP guidance for small-to-medium sized dietary supplement manufacturers regurgitates a lot of what has already been published in the regulation, but does bring fresh focus to matters such as expiration dates and ingredient supplier...

Measure your claims carefully in 2011, unless facing an FTC complaint is one of your New Year's Resolutions

10 New Year’s Resolutions for 2011

By Ivan Wasserman

2010 saw a flurry of enforcement activity by the Federal Trade Commission (FTC) based on claims made for dietary supplement and functional food products. There is no indication that 2011 will be any different.

Quality will improve under the Food safety Bill, says industry

Industry welcomes Food Safety Bill

Industry groups have welcomed the passage of the Food Safety Bill, highlighting lobbying efforts and Congressional support that kept potential burdens out of the amended legislation.

RockHard Weekend? Unlikely, after sildenafil detection and voluntary recall

Dietary supplements firm Hain gets FDA 483 warning

By Mike Stones

Long Island-based dietary supplement firm, Hain North America has received a warning letter outlining infringements of Good Management Practice (GMP) from the Food and Drug Administration (FDA).

Industry is finding the EU health claims system hard to swallow

Are health claims making your business sick?

By Shane Starling

2010 has been another tough year for the European functional food and supplements industries as health claim rejections have continued to flood in, leaving some in a state of high anxiety, fear and dread. Others are just mildly annoyed at a situation...

Signergy: Found to be contaminated in New Zealand

FDA takes hard line on erectile dysfunction supplement

By Shane Starling

In the same week the US Food and Drug Administration (FDA) announced an industry-backed crackdown on spiked weight loss, body building and sexual enhancement products, the agency issued an alert against a sulfoaildenafil-contaminated product called Man...

Dannon will continue making digestive health claims for Activia

Dannon on FTC settlement: “Our claims remain intact”

By Shane Starling

Dannon says its year-long negotiations with the Federal Trade Commission that resulted in a $21m settlement and modifications placed on its health statements, has not altered the core claims for its multi-million dollar selling probiotic yoghurts.

FDA: Ready to use

Industry welcomes FDA clampdown

By Shane Starling

The dietary supplements industry has backed the Food and Drug Administration in cracking down on products tainted with sibutramine, steroids and other substances.

ANH-USA says DS players have nothing to fear from the Food Safety Bill

Food Safety Bill won’t penalize dietary supplements players

By Shane Starling

Washington DC-based industry body the Alliance for Natural Health USA (ANH-USA) says the dietary supplements industry has been rewarded by the Food Safety Bill (S. 510), which could have included draconian measures to, “regulate away natural health”.

Duro has been pulled from the market by its maker

Contaminated herbal Viagra withdrawn

By Shane Starling

A herbal erectile dysfunction (ED) dietary supplement has been voluntary withdrawn from the US market by its Floridian manufacturer after it was alerted to a contamination problem with the unauthorized substance, sildenafil.

A transatlantic view of regulations and health claims

A transatlantic view of regulations and health claims

By Stephen Daniells

Should the FDA work to be more like EFSA? Speaking at the NutraIngredients Health Claims 2010 conference Andrew Shao said the two organisations are already very similar in the way they review scientific claims.

If POM's recent actions are anything to go by, it won't take the FTC's motion to dismiss lying down

FTC to POM: Our claim standards are not new

By Shane Starling

The Federal Trade Commission (FTC) says it has not set any new claim substantiation “rules” in a new court action against California-based pomegranate player, POM Wonderful.

Oats can reduce cholesterol says Health Canada, but supporting data has been called for

Health Canada criticized over health claim data

By Shane Starling

A former Health Canada official has criticized the agency for failing to publish health claim-backing data, after recently approving an oat fiber-cholesterol health claim.

Follow us

Products

View more

Webinars